New obesity drug, Meridia

March 1998

Knoll is promoting their new obesity drug, Meridia.

Meridia (sibutramine) inhibits the reuptake of norepinephrine and serotonin. It helps reduce appetite and increase metabolism.

Meridia leads to about a 5% to 10% weight loss. This doesn't sound like much, but it's sometimes enough to decrease the risk of hypertension, diabetes, etc.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Homocysteine may be an important risk factor for heart disease and stroke
Cardiology Whether patients on warfarin can take acetaminophen
Cardiology Patients can still take erythromycin to prevent bacterial endocarditis
Neurology & Pain Stronger warning about potential hepatotoxicity in patients taking Duract (bromfenac)
Obesity & Weight Loss New obesity drug, Meridia
Singulair (montelukast) for asthma
Serevent (salmeterol), is now approved for chronic obstructive pulmonary disease (COPD)
Gastroenterology PrevPac for H. pylori
Neurology & Pain Amerge (naratriptan) for migraines
Neurology & Pain Some Parkinson's patients will be taking Tasmar (tolcapone)
Women's Health New strength of Prempro
Women's Health Topical testosterone for libido
Venastat, a new herbal product for leg swelling due to varicose veins
Pediatrics Childhood vaccine recommendations
Pediatrics Syrup of ipecac isn't used much anymore
Diabetes Not to prescribe metformin (Glucophage) to patients with congestive heart failure
Diabetes Diabetics on calcium blockers suffer more Mis

New obesity drug, Meridia

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents